Form 8-K - Current report:
SEC Accession No. 0001437749-23-001446
Filing Date
2023-01-20
Accepted
2023-01-20 17:05:04
Documents
13
Period of Report
2023-01-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20230120_8k.htm   iXBRL 8-K 28914
  Complete submission text file 0001437749-23-001446.txt   165231

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nby-20230119.xsd EX-101.SCH 3593
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20230119_def.xml EX-101.DEF 11916
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20230119_lab.xml EX-101.LAB 15966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20230119_pre.xml EX-101.PRE 12127
7 EXTRACTED XBRL INSTANCE DOCUMENT nby20230120_8k_htm.xml XML 2654
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 23541732
SIC: 2834 Pharmaceutical Preparations